Investigation of hidden crisis of prescription drug abuse in Turkey: Pregabalin monitoring

Basit Öğe Kaydı
dc.authorid0000-0002-0306-4259
dc.authorid0000-0001-6577-0100
dc.authorid0000-0001-6047-2796
dc.contributor.authorBadur, İsa
dc.contributor.authorBilgin Badur, Naciye
dc.contributor.authorBerk, Barkın
dc.date.accessioned2022-11-30T07:44:17Z
dc.date.available2022-11-30T07:44:17Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Sinirbilim Ana Bilim Dalı
dc.description.abstractThis is a cross-sectional retrospective observational national study. Abuse/misuse of the pregabalin and related parameters analyzed. Pregabalin was mostly pre-scribed by general practitioners (26.2%). Pregabalin prescribing frequencies of other physicians were as follows, respectively: neurology (14.1%); mental health and illness (12%); physical therapy and rehabilitation (8.8%); internal medicine (4.8%). Accordingly, pregabalin (811.954box) and paracetamol, combinations excl. psycholeptics (1,131,069box) were the first two sales. In total cost of sales, pre-gabalin (57,721,322.00 TL) and methylphenidate (41,915,196.00 TL) were the top two sales rankings. According to the disposal results of ILAYS pharmaceuticals in 2020, pregabalin (2693box per year) and morphine (862box per year) were the most disposed drugs. It was determined that the frequency of pregabalin was fol-lowed by gabapentin. In conclusion, our study reveals the extent of abuse of prega-balin in Turkey with its data.
dc.identifier.citationBadur, İ., Bilgin Badur, N. ve Berk, B. (2022). Investigation of hidden crisis of prescription drug abuse in Turkey: Pregabalin monitoring. Acta Pharmaceutica Sciencia, 60(4), 313-323. https://doi.org/10.23893/1307-2080.APS6021
dc.identifier.doi10.23893/1307-2080.APS6021
dc.identifier.endpage323
dc.identifier.issn1307-2080
dc.identifier.issue4
dc.identifier.scopus2-s2.0-85141390615
dc.identifier.scopusqualityQ3
dc.identifier.startpage313
dc.identifier.urihttps://doi.org/10.23893/1307-2080.APS6021
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10046
dc.identifier.volume60
dc.indekslendigikaynakScopus
dc.institutionauthorBadur, İsa
dc.institutionauthorBilgin Badur, Naciye
dc.institutionauthorBerk, Barkın
dc.language.isoen
dc.publisherIstanbul Medipol University
dc.relation.ispartofActa Pharmaceutica Scienciaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectControlled Drug Pharmaco-Economy
dc.subjectDrug Abuse
dc.subjectPregabalin
dc.subjectPrescription Drug Monitoring
dc.titleInvestigation of hidden crisis of prescription drug abuse in Turkey: Pregabalin monitoring
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Badur-Isa-2022.pdf
Boyut:
267.04 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Eczacılık Fakültesi Makale Koleksiyonu
Sağlık Bilimleri Enstitüsü Diğer Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu